fbpx

Nyheder

Lundbeckfonden Ventures nyheder

Lundbeckfond Ventures is LFÍ Life Science Investments new name
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, announces it has successfully raised £18 million in new funding
Mette Kirstine Agger appointed Head of LFI Life Science Investments
1 63 64 65

Lundbeckfonden Ventures

Nyheder

Acacia Pharma Group PLC – Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
8. maj 2020
Acacia Pharma Group PLC – Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
7. maj 2020
Acacia Pharma Group PLC – Alessandro Della Chà appointed as Director of Acacia Pharma Group plc
9. april 2020